A

argenx

Develops antibody-based therapies for autoimmune diseases

Toxicologist, Late Stage Clinical Development and Established Assets

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeGhent, Belgium

About the Job

Requirements

  • At least 5 years of industry experience in a relevant position.
  • A Ph.D. degree or equivalent experience.
  • A degree in toxicology or equivalent.
  • Strong literature-mining skills and the ability to author technical and regulatory documents.
  • The ability to organize self and others effectively and work in a structured manner.
  • The ability to influence internal and external stakeholders and communicate clearly through presentations and written and verbal communication.

Responsibilities

  • Lead product risk assessments for late-stage and established assets, including assessing the safety of impurities and extractables and leachables throughout late-stage clinical development and for established medicines in compliance with current regulatory guidelines.
  • Support the lifecycle of established products, including presentation changes and license renewals.
  • Serve as the point of contact for colleagues in CMC/Technical Operations, Regulatory, EHS, and external partners, and collaborate with project toxicologists to respond to Health Authority questions.
  • Provide expert scientific advice on risk assessments of potential product impurities.
  • Serve as the single point of contact for impurity and extractables and leachables risk assessments in drug substances and drug products across the portfolio.
  • Support EHS by managing toxicological risk assessments linked to safety data sheets.
  • Outsource, guide, and approve toxicological evaluations of extractables and leachables profiles associated with container closure systems, devices, and manufacturing components.
  • Oversee application of risk-assessment methodologies, including PDE, TTC, and OEL, in accordance with ICH and EMA/FDA guidelines.
  • Interpret in silico (Q)SAR analyses with expert partners and, where appropriate, propose and evaluate in vitro and in vivo studies.
  • Collaborate with cross-functional teams to develop compliant and scientifically sound control strategies.
  • Develop best practices and identify resources, gaps, and opportunities for improvement; keep risk assessments current with industry trends and regulatory requirements.
  • Partner with regulatory colleagues and provide expert toxicology advice for assigned projects.
  • Maintain knowledge of the nonclinical sections of assigned projects' initial dossiers, advise on paths forward, support medical writing during authoring, and review nonclinical sections of regulatory documents for license maintenance, geographic expansion, and supplementary submissions.
  • Own nonclinical aspects of periodic safety reporting for assigned projects.
  • Support biological safety risk assessments of medical devices with expert partners and CMC.
  • Lead the toxicology team's responses to Health Authority questions during geographic expansion.
  • Coach and guide junior colleagues on the team.
  • Lead the network of external partners and, together with Global Sourcing, maintain and expand productive relationships.

Desired Qualifications

  • Professional board certification in toxicology, such as ERT or DABT.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs